Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Amortization of Deferred Charges: 2021-2025

Historic Amortization of Deferred Charges for P3 Health Partners (PIII) over the last 4 years, with Q3 2025 value amounting to $19.4 million.

  • P3 Health Partners' Amortization of Deferred Charges rose 5689.46% to $19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.1 million, marking a year-over-year increase of 6591.71%. This contributed to the annual value of $87000.0 for FY2024, which is 8156.78% down from last year.
  • As of Q3 2025, P3 Health Partners' Amortization of Deferred Charges stood at $19.4 million, which was up 5689.46% from $71000.0 recorded in Q2 2025.
  • P3 Health Partners' Amortization of Deferred Charges' 5-year high stood at $19.4 million during Q3 2025, with a 5-year trough of -$12.2 million in Q4 2024.
  • For the 4-year period, P3 Health Partners' Amortization of Deferred Charges averaged around $1.5 million, with its median value being $171936.0 (2021).
  • The largest annual percentage gain for P3 Health Partners' Amortization of Deferred Charges in the last 5 years was 1893384.62% (2024), contrasted with its biggest fall of 1830000.0% (2024).
  • Over the past 4 years, P3 Health Partners' Amortization of Deferred Charges (Quarter) stood at $1.3 million in 2021, then plummeted by 94.73% to $67000.0 in 2023, then crashed by 18300.0% to -$12.2 million in 2024, then surged by 259.18% to $19.4 million in 2025.
  • Its last three reported values are $19.4 million in Q3 2025, $71000.0 for Q2 2025, and $331000.0 during Q1 2025.